Angelman Syndrome Foundation

Applications are invited for Angelman syndrome-related research projects. One- and two-year grants of up to $100,000 per year will be awarded with priority given to projects focused on studying or correcting the heterozygous effect of non-UBE3A genes in deletion, the potential results of increasing UBE3A after therapies, or for some subtypes of AS, the delivery of therapies and potential for improvement, and symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.